Assessing diagnosis and managing respiratory and cardiac complications of sarcoglycanopathy
| Autor: | Valentina Pegoraro, Corrado Angelini |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
new genetic therapies
Bioinformatics 03 medical and health sciences SGCG 0302 clinical medicine Medicine Pharmacology (medical) cardiac complication limb-girdle muscular dystrophy physiotherapy rehabilitation respiratory involvement Sarcoglycan treatments Respiratory system Pharmacology Toxicology and Pharmaceutics (miscellaneous) Wasting SGCA business.industry Health Policy medicine.disease Sarcoglycanopathy 030220 oncology & carcinogenesis medicine.symptom business 030217 neurology & neurosurgery Sarcoglycanopathies Limb-girdle muscular dystrophy |
| Zdroj: | Expert Opinion on Orphan Drugs. 8:515-523 |
| ISSN: | 2167-8707 |
| DOI: | 10.1080/21678707.2020.1865916 |
| Popis: | Introduction: Sarcoglycanopathies (SG) are caused by a mutation in SGCA, SGCB, SGCG, or SGCD genes and present a wide spectrum of muscle involvement and wasting. The clinical phenotypes due to a mu... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|